Key Facts GPs Should Know About GLP-1 Analogs
Family Medicine Initiative
APRIL 9, 2024
Demand for new obesity medications like semaglutide (GLP-1 analogs) is high, but availability is low. I therefore reviewed the main research studies and guidelines and tried to summarize them briefly and clearly in this article. Stopping the medication leads to a rebound effect (½ – ⅔ weight regain after one year).
Let's personalize your content